Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Organigram Global Inc.NASDAQ: OGI

Total Equity · Q2 FY2026 · quarter ended Mar 2026

Total equity falls 4.6% from a year ago

Total equity stood at CA$372.77M at the end of Q2 FY2026, down 4.6% from a year earlier and up 1.0% from the prior quarter.

Context

  • Total equity amounted to 71.3% of total assets at the end of Q2 FY2026, down 1.3 pp from a year earlier.
  • Total equity increased in 2 of the last 3 fiscal years.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -4.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$372.77M+1.0% QoQ
Last fiscal yearSep 2025
CA$349.13M+14.1% YoY
Year agoMar 2025
CA$390.57M-4.6% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.6%——
1 year+14.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Equity history

CAD · from the balance sheet

Latest · FY2025
349.13M CAD
Year-over-year change
+14.1%
4-year CAGR
-7.6%

Total Equity vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -4.6% is the 7th highest of 9, against a peer median of +27.5%.
  • Total equity amounts to 71.3% of total assets for OGI, versus a peer median of 51.4%.
OGI Competitors
Total Equity for OGI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ACBAurora Cannabis Inc.Mar 2026CA$513.15M CAD-15.2%-0.6%85.2%
OGIOrganigram Global Inc.Mar 2026CA$372.77M CAD-4.6%—71.3%
HSDTSolana CompanyMar 2026$197.9M USD+15360.7%+233.0%98.6%
INFUInfuSystem Holdings, Inc.Mar 2026$58.75M USD+6.5%+6.1%59.5%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026$50.97M USD+202.3%+6.5%50.6%
ELMDElectromed, Inc.Mar 2026$49.17M USD+11.9%+8.1%82.7%
DERMJourney Medical CorporationMar 2026$30.83M USD+43.1%+23.3%33.7%
LFCRLifecore Biomedical, Inc.Dec 2025-$14.2M USD——6.1%
IVAInventiva S.A.Dec 2025-€29.04M EUR+72.8%—11.7%
RNACCartesian Therapeutics, Inc.Mar 2026-$148.12M USD-579.8%—51.4%
Peer median (excluding OGI) —+27.5%+7.3%51.4%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents55.37M68.52M33.86M106.75M28.2M
Short-term Investments128.48M30.4M0821K826K
Net Receivables21M46.37M27.46M37.15M64.86M
Inventory48.82M68.28M80.95M82.52M123.95M
Other Current Assets5.51M2.21M13.7M25.86M55.39M
Total Current Assets260.62M221.62M155.98M262.22M284.9M
Property, Plant & Equipment (Net)235.94M259.82M99.05M96.23M122.98M
Goodwill14.32M41.98M0052.52M
Intangible Assets2.73M14.26M10.62M8.09M48.51M
Long-term Investments6.11M7.07M13.72M40.73M49.55M
Tax Assets3.2M0000
Other Non-current Assets31.11M32.36M19.09M591K3.75M
Total Non-current Assets293.4M355.48M142.48M145.64M277.31M
Total Assets554.02M577.11M298.46M407.86M562.21M
Account Payables18.95M40.86M14.73M47.1M89.25M
Short-term Debt80K80K76K60K25K
Tax Payables01.42M94K00
Deferred Revenue02.44M000
Other Current Liabilities6.25M12M2.35M5.14M35.91M
Total Current Liabilities26.27M55.29M22.43M53.32M126.16M
Long-term Debt230K155K3.63M25K0
Deferred Tax Liabilities03.62M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities43.07M7.79M771K45.18M79.17M
Total Non-current Liabilities47.95M13.76M4.4M48.55M86.92M
Total Liabilities74.21M69.05M26.83M101.87M213.08M
Common Stock730.8M769.73M776.91M852.89M919.91M
Retained Earnings(275.64M)(289.93M)(538.53M)(583.97M)(608.73M)
Accumulated OCI24.65M28.26M33.25M37.07M37.95M
Other Stockholders Equity00000
Minority Interest00000
Total Equity479.81M508.06M271.62M305.99M349.13M
Total Debt5.95M3.36M3.71M4.46M8.75M
Net Debt(49.42M)(65.16M)(30.16M)(102.29M)(19.45M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.